Literature DB >> 2990395

Early prenatal diagnosis of inborn error of metabolism: a case report of a fetus affected with Fabry's disease.

O Tsutsumi, M Sato, K Sato, K Sato, M Mizuno, S Sakamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2990395     DOI： 10.1111/j.1447-0756.1985.tb00045.x

Source DB:  PubMed          Journal:  Asia Oceania J Obstet Gynaecol        ISSN： 0389-2328


× No keyword cloud information.
  6 in total

Review 1.  Renal complications of Fabry disease in children.

Authors:  Behzad Najafian; Michael Mauer; Robert J Hopkin; Einar Svarstad
Journal:  Pediatr Nephrol       Date:  2012-08-17       Impact factor: 3.714

2.  Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.

Authors:  Behzad Najafian; Einar Svarstad; Leif Bostad; Marie-Claire Gubler; Camilla Tøndel; Chester Whitley; Michael Mauer
Journal:  Kidney Int       Date:  2010-12-15       Impact factor: 10.612

3.  Perspectives: on Precision Nutrition Research in Heart, Lung, and Blood Diseases and Sleep Disorders.

Authors:  Charlotte A Pratt; Alison G M Brown; Shilpy Dixit; Nicole Farmer; Aruna Natarajan; Josephine Boyington; Scarlet Shi; Qing Lu; Paul Cotton
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

Review 4.  Assessment of renal pathology and dysfunction in children with Fabry disease.

Authors:  Uma Ramaswami; Behzad Najafian; Arrigo Schieppati; Michael Mauer; Daniel G Bichet
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

5.  Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy.

Authors:  Brent Fall; C Ronald Scott; Michael Mauer; Stuart Shankland; Jeffrey Pippin; Jonathan A Jefferson; Eric Wallace; David Warnock; Behzad Najafian
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

6.  Fabry disease in children and the effects of enzyme replacement treatment.

Authors:  Guillem Pintos-Morell; Michael Beck
Journal:  Eur J Pediatr       Date:  2009-02-26       Impact factor: 3.183
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.